exclusive license

Taiwan's TaiGen Biotechnology Company Ltd inks exclusive deal with Russia's R-Pharm for nemonoxacin

TaiGen Biotechnology Company Ltd, a biotechnology firm in Taiwan, has given Russia's R-Pharm the exclusive license to develop and commercialize the anti-infective compound nemonoxacin in the Russian Federation, Turkey and the Commonwealth of Independent States.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics